Chief Technology Officer at Exothera
Hanna has made her whole career in the gene therapy field. Over the years she has been in several directors’ positions leading research and development at FKD Therapies, Finvector and Kuopio Center for Gene and Cell Therapy. Her research interest has focused on gene therapy and translational development, including early stage analyticals and the development of scalable, robust manufacturing processes operating under current regulatory guidelines. Her PhD was in Molecular Medicine, obtained from the University of Kuopio. She followed up her PhD with post doc work at the University of California San Diego UCSD, CA, USA, and the University of Eastern Finland, Kuopio, Finland. She has several patents related to vector manufacturing.